Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
Read Now: Expert Opinions on HIV Cure Research
  
  • Email Email
  • Comments Comments
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

International News

Barriers to Implementation of Isoniazid Preventive Therapy in HIV Clinics: A Qualitative Study

January 21, 2011

Advertisement

Though isoniazid preventive therapy (IPT) has been shown to reduce TB incidence among people with HIV, and is recommended in an HIV care program in Gauteng province, its implementation there is low, the study authors noted. Based on in-depth interviews and a focus group discussion, they described barriers to IPT implementation in the donor-funded program as well as provider and patient perspectives on IPT.

The team interviewed 22 clinic staff and 20 patients from 10 purposively selected HIV clinics in the program. Staff members were surveyed about their knowledge of and experience with IPT and about barriers to its implementation. Patients were asked their opinions about IPT.

The primary barriers to IPT were lack of knowledge and experience, staff reported. Prescribers were unaware of IPT benefits and unclear about guidelines. Other barriers included the belief that TB screening tools are inaccurate in HIV patients and the need to refer patients to separate clinics to conduct TB screenings. None of the patients had ever heard of IPT.

"Barriers to the widespread use of IPT primarily derived from health care workers, in particular lack of experience among physicians," the authors concluded. "In addition to overcoming operational barriers, a change in health care worker perception is needed if IPT is to be widely used; we suggest local clinical opinion leaders could help achieve this."

Back to other news for January 2011

Adapted from:
AIDS
11.2010; Vol. 24; Suppl. 5: P. S45-S48; Rebecca Lester; Robin Hamilton; Salome Charalambous; Thobeka Dwadwa; Clare Chandler; Gavin J. Churchyard; Alison D. Grant


  
  • Email Email
  • Comments Comments
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.
 
See Also
Tuberculosis (TB) Fact Sheet
Questions and Answers About Tuberculosis
More on Tuberculosis Prevention and Diagnosis in HIV-Positive Patients

No comments have been made.
 

Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)

Your Name:


Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining:

Tools
 

Advertisement